AIGH Capital Management LLC - Q1 2022 holdings

$408 Million is the total value of AIGH Capital Management LLC's 83 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 44.0% .

 Value Shares↓ Weighting
IWM NewISHARES TRput$104,893,000511,000
+100.0%
25.73%
INTC NewINTEL CORPcall$25,126,000511,000
+100.0%
6.16%
SIMO BuySILICON MOTION TECHNOLOGY COsponsored adr$25,030,000
-27.8%
374,600
+2.6%
6.14%
-42.0%
PDFS SellPDF SOLUTIONS INC$23,963,000
-25.0%
859,812
-14.4%
5.88%
-39.7%
DZSI BuyDZS INC$21,753,000
+14.6%
1,568,344
+34.1%
5.34%
-7.8%
PLAB SellPHOTRONICS INC$20,699,000
-11.5%
1,219,740
-1.7%
5.08%
-28.8%
CYBE BuyCYBEROPTICS CORP$20,693,000
-10.8%
509,917
+2.2%
5.08%
-28.3%
ADTN BuyADTRAN INC$18,427,000
-7.0%
998,735
+15.1%
4.52%
-25.2%
AVEO BuyAVEO PHARMACEUTICALS INC$15,765,000
+31.5%
2,820,157
+10.3%
3.87%
+5.8%
CAMP NewCALAMP CORP$12,958,0001,772,617
+100.0%
3.18%
AVNW BuyAVIAT NETWORKS INC$12,551,000
+2.5%
407,918
+6.9%
3.08%
-17.5%
MRAM SellEVERSPIN TECHNOLOGIES INC$11,186,000
-36.3%
1,284,249
-17.4%
2.74%
-48.8%
EOLS NewEVOLUS INC$10,249,0001,101,240
+100.0%
2.51%
PRTK BuyPARATEK PHARMACEUTICALS INC$9,325,000
-11.2%
3,139,714
+34.2%
2.29%
-28.6%
SCYX BuySCYNEXIS INC$8,751,000
-32.6%
2,238,136
+5.1%
2.15%
-45.8%
SCPH BuySCPHARMACEUTICALS INC$7,933,000
+15.1%
1,396,724
+1.7%
1.95%
-7.4%
THTX BuyTHERATECHNOLOGIES INC$7,335,000
-15.9%
2,963,067
+2.8%
1.80%
-32.3%
EDAP SellEDAP TMS S Asponsored adr$4,548,000
-36.6%
627,316
-47.7%
1.12%
-49.1%
LPTH BuyLIGHTPATH TECHNOLOGIES INC$4,019,000
+20.2%
2,039,832
+48.8%
0.99%
-3.3%
RFIL BuyRF INDS LTD$3,692,000
-6.8%
512,037
+3.4%
0.91%
-24.9%
BKTI BuyBK TECHNOLOGIES CORPORATION$3,503,000
+8.5%
1,373,750
+2.5%
0.86%
-12.8%
ARDX BuyARDELYX INC$3,333,000
+26.2%
3,114,602
+29.7%
0.82%
+1.4%
WTT BuyWIRELESS TELECOM GROUP INC$3,221,000
-21.6%
1,872,639
+0.3%
0.79%
-37.0%
MDNA BuyMEDICENNA THERAPEUTICS CORP$2,907,000
-19.5%
2,272,700
+2.6%
0.71%
-35.2%
VCNX NewVACCINEX INC$2,627,0002,081,801
+100.0%
0.64%
MYO BuyMYOMO INC$2,351,000
-42.9%
617,179
+2.5%
0.58%
-54.1%
NBSE BuyNEUBASE THERAPEUTICS INC$1,932,000
-31.3%
1,027,585
+2.7%
0.47%
-44.7%
BuyIDEAL PWR INC$1,877,000
-22.1%
213,368
+6.8%
0.46%
-37.4%
YTEN BuyYIELD10 BIOSCIENCE INC$1,821,000
+8.2%
343,685
+0.5%
0.45%
-12.9%
PDSB SellPDS BIOTECHNOLOGY CORP$1,750,000
-29.9%
282,609
-8.3%
0.43%
-43.6%
XFOR SellX4 PHARMACEUTICALS INC$1,746,000
-47.9%
997,719
-31.9%
0.43%
-58.1%
ABEO BuyABEONA THERAPEUTICS INC$1,583,000
+313.3%
5,025,100
+341.9%
0.39%
+231.6%
SLNO NewSOLENO THERAPEUTICS INC$1,516,0006,800,000
+100.0%
0.37%
RZLT BuyREZOLUTE INC$1,423,000
+12.3%
420,913
+58.7%
0.35%
-9.6%
CLRB BuyCELLECTAR BIOSCIENCES INC$1,263,000
+111.9%
1,837,046
+104.9%
0.31%
+70.3%
BLIN SellBRIDGELINE DIGITAL INC$1,261,000
-36.4%
660,521
-24.7%
0.31%
-48.8%
NLSPW  NLS PHARMACEUTICS LTDcall$1,167,000
+27.0%
827,9210.0%0.29%
+2.1%
CYTHW  CYCLO THERAPEUTICS INCcall$935,000
-15.0%
294,9310.0%0.23%
-31.6%
PCSA  PROCESSA PHARMACEUTICALS INC$915,000
-38.5%
303,7030.0%0.22%
-50.7%
HSDT BuyHELIUS MED TECHNOLOGIES INC$845,000
-34.9%
255,400
+2.2%
0.21%
-47.7%
AMPG NewAMPLITECH GROUP INC$461,000137,372
+100.0%
0.11%
FKWL SellFRANKLIN WIRELESS CORP$394,000
-76.9%
98,826
-74.7%
0.10%
-81.3%
ExitCOGNITION THERAPEUTICS INC$0-25,496
-100.0%
-0.05%
ExitDERMATA THERAPEUTICS INCcall$0-175,000
-100.0%
-0.09%
ExitPETVIVO HLDGS INCcall$0-100,000
-100.0%
-0.12%
NMTC ExitNEUROONE MED TECHNOLOGIES CO$0-475,000
-100.0%
-0.28%
BWAY ExitBRAINSWAY LTDsponsored ads$0-207,847
-100.0%
-0.49%
ExitCONTEXT THERAPEUTICS INC$0-762,721
-100.0%
-0.62%
EMKR ExitEMCORE CORP$0-293,349
-100.0%
-0.62%
ALNA ExitALLENA PHARMACEUTICALS$0-4,000,000
-100.0%
-0.72%
ExitALIMERA SCIENCES INC$0-497,639
-100.0%
-0.78%
RNAZ ExitTRANSCODE THERAPEUTICS INC$0-1,270,600
-100.0%
-0.98%
HTGM ExitHTG MOLECULAR DIAGNOSTICS IN$0-612,000
-100.0%
-1.01%
OIIM ExitO2MICRO INTERNATIONAL LIMITEspons adr$0-871,051
-100.0%
-1.20%
LTRX ExitLANTRONIX INC$0-688,309
-100.0%
-1.64%
MIRM ExitMIRUM PHARMACEUTICALS INC$0-337,917
-100.0%
-1.64%
ExitPARABELLUM ACQUISITION CORPcall$0-589,286
-100.0%
-1.75%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AVIAT NETWORKS INC12Q3 20236.8%
SCPHARMACEUTICALS INC12Q3 20238.5%
THERATECHNOLOGIES INC11Q2 20232.9%
FRANKLIN WIRELESS CORP11Q3 20232.9%
IDEAL PWR INC11Q3 20232.5%
MEDICENNA THERAPEUTICS CORP11Q3 20231.1%
PARATEK PHARMACEUTICALS INC10Q1 20233.2%
LIGHTPATH TECHNOLOGIES INC10Q3 20233.0%
MYOMO INC10Q3 20231.3%
DZS INC9Q1 20237.5%

View AIGH Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
AIGH Capital Management LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bridgeline Digital, Inc.May 21, 2021627,4199.7%

View AIGH Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-15
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-11-12

View AIGH Capital Management LLC's complete filings history.

Compare quarters

Export AIGH Capital Management LLC's holdings